
Her-Tinib Tablet
Marketer
Adley Formulations
Salt Composition
Lapatinib (250mg)
Overview Her-Tinib Tablet
Tivitinib tablets are indicated for breast cancer management. This medication inhibits or reduces the proliferation of cancerous cells. It's administered either independently or alongside other therapies to manage advanced breast cancer. Tivitinib should be ingested on an empty stomach, or at least one hour prior to, or two hours following, a meal. Dosage and treatment length are individualized based on disease severity and treatment response. Adhere strictly to the prescribed regimen to minimize adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months; discontinue only under physician guidance. Common side effects include nausea, headache, backache, and respiratory distress. Severe diarrhea may occur; increased fluid intake or medical consultation is advised if this develops. Regular blood pressure monitoring is often necessary. Report severe headache, disorientation, visual disturbances, persistent nausea, or vomiting to your physician. Liver function assessments are typically conducted before, during, and after treatment. Prior to commencing Tivitinib, disclose any pre-existing liver or kidney conditions. Potential drug interactions exist; inform your healthcare provider of all concurrent medications. Use during pregnancy or breastfeeding is contraindicated. Reliable contraception for both partners is crucial during treatment to prevent conception.
Uses of Her-Tinib Tablet
Malignant breast tumor
Major Benefits of Her-Tinib Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Her-Tinib Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Her-Tinib Tablet:
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use Her-Tinib Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Her-Tinib Tablet on an empty stomach.
How Her-Tinib Tablet works:
Her-Tinib tablets are an anti-neoplastic agent targeting HER2 and EGFR receptors. By blocking these receptors, responsible for excessive cell growth, it prevents the uncontrolled proliferation of cancer cells and their associated signaling cascades.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Her-Tinib Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Her-Tinib tablets during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Lactation and Her-Tinib tablets are incompatible; evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Her-Tinib tablets might impair your driving ability due to potential side effects.
KidneyCAUTION
Patients with severe kidney impairment should use Her-Tinib tablets cautiously, as dose modification may be necessary. Advice from a physician is recommended. Data regarding Her-Tinib tablet use in such patients is limited. Dosage changes are not advised for individuals with mild or moderate kidney disease.
LiverCAUTION
Patients with liver impairment should use Her-Tinib Tablet cautiously, as dose modification may be necessary. Consult your physician for guidance. Data regarding Her-Tinib Tablet use in individuals with severe hepatic dysfunction is limited.
What if you forget to take Her-Tinib Tablet :
Omit a Her-Tinib Tablet dose? Seek your physician's advice.
Facts to Know About Her-Tinib Tablet
| Label | Value |
|---|---|
| Type of Compound | Quinazoline-based amines |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Agents that block tyrosine kinase enzymes |
